Showing results (391-400 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.Nature Cancer|February 5, 2022
APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasisSonja M Wörmann, Amy Zhang, Fredrik I Thege, et al.Nature Cancer|February 5, 2022
The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targetsZhongyi Hu, Jiao Yuan, Meixiao Long, et al.Nature Cancer|February 5, 2022
The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countriesEduardo Edelman Saul, Raquel B Guerra, Michelle Edelman Saul, et al.Nature Cancer|February 5, 2022
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemiaMari Hashimoto, Yoriko Saito, Ryo Nakagawa, et al.Nature Cancer|February 5, 2022
Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanomaRached Alkallas, Mathieu Lajoie, Dan Moldoveanu, et al.Nature Cancer|February 5, 2022
Delineating the evolutionary dynamics of cancer from theory to realityIvana Bozic, Catherine J WuNature Cancer|February 5, 2022
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancyJulie S Di Martino, Ana Rita Nobre, Chandrani Mondal, et al.Nature Cancer|February 5, 2022
The current landscape of immunotherapy for pediatric brain tumorsEugene I Hwang, Elias J Sayour, Catherine T Flores, et al.Nature Cancer|February 5, 2022
Overcoming therapy resistance in EGFR-mutant lung cancerAntonio Passaro, Pasi A Jänne, Tony Mok, et al.Pageof 65